| Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial RO Dillman, J Herndon, SL Seagren, WL Eaton Jr, MR Green JNCI: Journal of the National Cancer Institute 88 (17), 1210-1215, 1996 | 1295 | 1996 |
| Analysis of e-waste recycling behavior based on survey at a Midwestern US University AL Arain, R Pummill, J Adu-Brimpong, S Becker, M Green, M Ilardi, ... Waste Management 105, 119-127, 2020 | 119 | 2020 |
| Targeting immune checkpoints in unresectable metastatic cutaneous melanoma: a systematic review and meta‐analysis of anti‐CTLA‐4 and anti‐PD‐1 agents trials S Yun, ND Vincelette, MR Green, AE Wahner Hendrickson, I Abraham Cancer medicine 5 (7), 1481-1491, 2016 | 118 | 2016 |
| Update on aurora kinase targeted therapeutics in oncology MR Green, JE Woolery, D Mahadevan Expert Opinion on Drug Discovery 6 (3), 291-307, 2011 | 99 | 2011 |
| Renal dysfunction during and after high-dose methotrexate MR Green, MC Chamberlain Cancer Chemotherapy and Pharmacology 63 (4), 599-604, 2009 | 72 | 2009 |
| Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma MR Green, S Chowdhary, KM Lombardi, LM Chalmers, M Chamberlain Expert Review of Neurotherapeutics 6 (5), 635-652, 2006 | 54 | 2006 |
| Olanzapine is effective for refractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity S Vig, L Seibert, MR Green Journal of cancer research and clinical oncology 140, 77-82, 2014 | 40 | 2014 |
| Management of toxicities associated with high-dose interleukin-2 and biochemotherapy JC Poust, JE Woolery, MR Green Anti-cancer drugs 24 (1), 1-13, 2013 | 38 | 2013 |
| Development of daptomycin resistance in a bone marrow transplant patient with vancomycin-resistant Enterococcus durans MR Green, C Anasetti, RL Sandin, NE Rolfe, JN Greene Journal of Oncology Pharmacy Practice 12 (3), 179 - 181, 2006 | 36 | 2006 |
| Off-target effects of BCR-ABL and JAK2 inhibitors MR Green, MD Newton, KM Fancher American Journal of Clinical Oncology 39 (1), 76-84, 2016 | 34 | 2016 |
| Combination capecitabine and bevacizumab in the treatment of metastatic hepatic epithelioid hemangioendothelioma A Lau, S Malangone, M Green, A Badari, K Clarke, E Elquza Therapeutic Advances in Medical Oncology 7 (4), 229-236, 2015 | 32 | 2015 |
| A sociodemographic data collection model for cooperative clinical trials JC Holland, J Herndon, AB Kornblith, DF Cella, MR Cooper, M Green, ... Proc Am Soc Clin Oncol 11 (157), 445, 1992 | 27 | 1992 |
| Optimising absorption of posaconazole MR Green, JE Woolery Mycoses 54, e775 - e779, 2011 | 21 | 2011 |
| Chemotherapy and radiation therapy as compared with radiation therapy in stage III non-small-cell cancer. RL Souhami, SG Spiro, M Cullen The New England journal of medicine 324 (16), 1136-1137, 1991 | 18 | 1991 |
| Posaconazole Serum Level on Day 2 Predicts Steady State Posaconazole Serum Level MR Green, JE Woolery Therapeutic Drug Monitoring 34 (1), 118 - 119, 2012 | 15 | 2012 |
| A phase II study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell … HB Neill, AA Miller, GH Clamon, MC Perry, J Crawford, MR Green Seminars in oncology 24 (4 Suppl 12), S12-130, 1997 | 13 | 1997 |
| Prostate cancer-associated disseminated intravascular coagulation with excessive fibrinolysis treated with Degarelix SY Ong, J Taverna, C Jokerst, T Enzler, E Hammode, E Rogowitz, ... Case Reports in Oncological Medicine 2015, 2015 | 12 | 2015 |
| Oncology pharmacy education and training in the United States schools of pharmacy J Kwon, D Ledvina, M Newton, MR Green, R Ignoffo Currents in Pharmacy Teaching and Learning 7 (4), 451-457, 2015 | 12 | 2015 |
| High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma CJ Campen, RL Tombleson, MR Green Journal of neuro-oncology 101, 345-355, 2011 | 12 | 2011 |
| Therapeutic drug monitoring and dose adjustment of posaconazole oral suspension in adults with acute myeloid leukemia SE Hummert, MR Green Therapeutic Drug Monitoring 37 (4), 508-511, 2015 | 11 | 2015 |
Hani Babiker, MDMayo ClinicVerified email at mayo.edu
